Day: December 10, 2024

Nokia CorporationStock Exchange Release10 December 2024 at 22:30 EET Nokia Corporation: Repurchase of own shares on 10.12.2024 Espoo, Finland – On 10 December 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 872,093 4.18CEUX – –BATE – –AQEU – –TQEX – –Total 872,093 4.18* Rounded to two decimals On 22 November 2024, Nokia announced that its Board of Directors is initiating a share buyback program to offset the dilutive effect of new Nokia shares issued to the shareholders of Infinera Corporation and certain Infinera Corporation share-based incentives. The repurchases in compliance with the Market Abuse Regulation (EU) 596/2014...

STOCKHOLM, SWEDEN, December 10, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) divests 4,6 million shares in the portfolio company OssDsign and thereby strengthens the investment company’s liquidity. Karolinska Development holds nearly 5 million shares in OssDisgn after the divestment. The divestment is being carried out in two stages, as the acquirer, Linc AB, following the transaction, will exceed (directly and indirectly) 10 percent of the voting rights in OssDsign. On December 10, 2024, 4.4 million shares were sold through a direct sale to Linc AB, while the sale of an additional 200,000 shares is conditional upon approval from the Inspectorate for Strategic Products under the Act (2023:560) on the Review of Foreign Direct Investments. The divestment provides Karolinska Development with a total capital infusion of approximately...

PASCAGOULA, Miss., Dec. 10, 2024 (GLOBE NEWSWIRE) — HII (NYSE: HII) announced today that Jennifer Childs has been named vice president of quality and engineering of the company’s Ingalls Shipbuilding division, effective Jan. 6, 2025. She succeeds Brian Blanchette, incoming vice president of HII and president of Ingalls Shipbuilding. Childs, a former Navy surface warfare officer (nuclear), has been with Ingalls for 17 years and previously served as director of technical & design engineering. She will now be responsible for the management and oversight of quality programs, and of ship design, engineering, integrated logistics support and planning yard engineering. “Jennifer’s technical acumen is matched by her commitment to developing talent and fostering a culture of innovation within her team,” incoming Ingalls Shipbuilding...

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN.THIS PRESS RELEASE IS AN ADVERTISEMENT AND NOT A PROSPECTUS WITHIN THE MEANING OF REGULATION (EU) 2017/1129 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL OF JUNE 14, 2017 Press Release Atos SE announces the completion of the settlement and delivery of its €233 million rights issue Paris, France – December 10, 2024 – Following the announcement on December 2, 2024 by Atos SE (Euronext Paris : ATO) (the “Company” or “Atos”) of the results of its rights issue of 233 million euros (the “Rights Issue”), Atos announces today that it has completed the settlement and delivery of the Rights Issue and the admission of the new shares to trading on the regulated market of Euronext Paris (“Euronext Paris”). As a result, the Rights Issue was subscribed...

MONTREAL, Dec. 10, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the United States Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) goal date of March 25, 2025 to the Company’s recently submitted supplemental Biologics License Application for the F8 formulation of tesamorelin. If approved by the FDA, the F8 formulation is intended to replace the F4 formulation, which is sold in the U.S. under the trade name EGRIFTA SV®. The new formulation is patent protected in the U.S. until 2033. About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development...

WARREN, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, today announced that Founder and CEO Ryan Saadi, MD, MPH, will be attending the J.P. Morgan Healthcare Conference, January 13-16, 2025, in San Francisco, CA. The J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together key stakeholders to discuss innovations and advancements in the sector. For inquiries about Tevogen Bio’s JP Morgan events, please contact Communications at communications@tevogen.com About Tevogen Bio Tevogen is a clinical-stage specialty immunotherapy company harnessing...

NOW AVAILABLE IN DISPENSARIES ACROSS ONTARIO JUST IN TIME FOR DRY JANUARY TORONTO, Dec. 10, 2024 (GLOBE NEWSWIRE) — The Boston Beer Company, makers of fan-favourite TeaPot, today unveils Emerald Hour, a line of non-alcoholic “Cali Sober” cannabis cocktails. These premium rosin-infused beverages represent the height of the cannabis beverage experience and are now available at licensed cannabis retailers in Ontario.Emerald Hour blends fresh-frozen cannabis extracts with regionally sourced cocktail ingredients to create a truly amazing full-spectrum beverage experience. Each 355mL can contains 10mg of THC and is made without the use of chemical solvents, making Emerald Hour a perfect choice for consumers seeking a stronger, booze-free happy hour.“We know many folks want great-tasting and premium alternatives to alcohol, and Emerald...

LOS ANGELES, Dec. 10, 2024 (GLOBE NEWSWIRE) — LiveOne (NASDAQ: LVO), an award-winning, creator-first, music, entertainment, and technology platform, announced today an exclusive audio advertising partnership with DAX, a leading digital advertising platform in the United States. Under the terms of the agreement, DAX will serve as LiveOne’s exclusive audio advertising sales partner in the U.S. This partnership is expected to significantly enhance LiveOne’s audio ad monetization capabilities, with projected improvements of programmatic audio advertising revenues. “We’re excited to partner with DAX to maximize our advertising opportunities and provide the best value in music to consumers,” said Bill Wittress, SVP of Business Development and Strategic Partnerships for LiveOne. “I’m thrilled that we’re...

PHILADELPHIA, Dec. 10, 2024 (GLOBE NEWSWIRE) — Brandywine Realty Trust (NYSE:BDN) announced today that its Board of Trustees has declared a quarterly cash dividend of $0.15 per common share and OP Unit payable on January 23, 2025 to holders of record on January 8, 2025. The quarterly dividend is equivalent to an annual rate of $0.60 per share. Conference Call and Audio Webcast We will release our fourth quarter earnings after the market close on Tuesday February 4, 2025 and will hold our fourth quarter conference call on Wednesday February 5, 2025 at 9:00 a.m. Eastern Time. To access the conference call by phone, please visit link here, and you will be provided with dial in details. A live webcast of the conference call will also be available on the Investor Relations page of our website at www.brandywinerealty.com. About Brandywine...